PIK3CG and pancreatic neoplasm: Moreover, KEGG pathway enrichment indicated anti-pancreatic cancer effects closely linked to the PI3K-Akt/mTOR signaling axis, one of the most frequently activated pathways in cancers, promoting cell survival, proliferation, and resistance to anticancer therapies44.